Funding round-up: Vitestro, Sunrise, Fire1, Seamless Therapeutics

Germany: Seamless Therapeutics, a biotech company, has raised a US$12.5m in a seed financing round that will accelerate development of its designer recombinases, a novel gene editing platform to transform the treatment of severe diseases. The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a German government…

You must be a HMI Subscriber to view this content.

Subscribe Now »